1 / 50

MASHIV

MASHIV. Multi-Agent Simulation of HIV in MSM Communities A Study of Concurrency. Robert Puckett, UH Manoa , November 20, 2014. Outline. Core Concepts HIV Concurrency MSM Agents MASHIV System Design HIV Model Agents Sexual Negotiation Modes of Operation Q & A. Research Questions.

rbrooke
Download Presentation

MASHIV

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. MASHIV Multi-Agent Simulation of HIV in MSM CommunitiesA Study of Concurrency Robert Puckett, UH Manoa, November 20, 2014

  2. Outline • Core Concepts • HIV • Concurrency • MSM • Agents • MASHIV System Design • HIV Model • Agents • Sexual Negotiation • Modes of Operation • Q & A

  3. Research Questions • Can a multi-agent simulation of individual level HIV transmission illuminate the impact that concurrent sexual relationships have on the HIV epidemic in MSM communities? • What is the impact of PrEP amid concurrency on the resulting HIV epidemic? • Can we overcome stochastic variability to provide consistent analysis and recommendations?

  4. Really Quick Overview Core concepts

  5. HIV Stages • Primary/Acute HIV Infection (PHI) • Virulence: High • Estimated 43% of infections due to PHI period [Wawer] • Occurs 2-4 weeks after exposure • Duration: 1.5 – 12 months [Blaser, 2013] • Only 2/3 experience symptoms • Fever, fatigue, pharyngitis, weight loss, night sweats, lymphadenopathy, myalgia, headache, nausea • Symptoms commonly result in misdiagnosis • Correctly diagnosed as PHI in 1000 of 60 million cases • HIV undetectable by antibody tests for several weeks into PHI [Coplan]

  6. HIV Stages • Asymptomatic Period • Virulence: Low, but present • Duration: 8+ years, untreated • Acquired Immuno-deficiency Syndrome (AIDS) • Immune system badly damaged (CD4 count < 200) • Susceptible to • Opportunistic infections • Certain cancers • Life expectancy • 1-3 years depending on presence of opportunistic infections

  7. Viral Plasma Load by Stage

  8. Concurrency Serial Monogamy time 1 2 3 4 5 Concurrent partnerships time 1 2 3 4 5 • ”Overlapping sexual partnerships where sexual intercourse with one partner occurs between two acts of intercourse with another partner.” [UNAIDS, 2009] • Key Components • Duration of relationships • Contact frequency • Number of partners • Virulence of partners

  9. monogamy concurrency Concurrency & PHI • The concern • Concurrent relationships will create a highly connected/reachable sexual network • PHI stage is highly virulent, unlikely to be detected • Result • Waves of PHI stage HIV infection sweep through sexual network

  10. The MSM Community • MSM – Behavior specific term • Includes gay, bisexual, male sex workers, transgendered • Any other men who engage in same-gendered sex • Statistics • 51 % of new HIV cases in the US were MSM • 14-19% of urban MSM are HIV+ [Goodreau 2007] • HIV prevalence in MSM increasing in most developed countries since 90s [Grulich 2008]

  11. MSM & HIV Risk • Risk Factors • Unprotected Anal Receptive Sex (UAR) • Disproportionately affected by STIs [Goodreau] • Other behavioral factors • “Bareback “ sex seeking, sero-sorting, high-risk venues • Higher proportion of concurrent relationships? • Concurrent relationships • General US Population: 11% of men • San Francisco urban MSM cohort: 78% of men • Note: vastly different sample populations • Less sexual role segregation • Heterosexual sexual role defined by gender • MSM sexual role defined by preference (insertive/receptive) • Role versatility allows HIV to spread more easily

  12. An Overview Multi-agent systems

  13. What are Agents? • A programming construct meant to represent a real-life entity or role • Key characteristics • Autonomous • Goal oriented • Self-organizing • Exist in / React to environment • Local knowledge • Decentralized • Compete, coordinate, cooperate • In an individual-level multi-agent simulation of HIV • 1 agent == 1 person

  14. Multi-Agent System • The Agents • Cognitive model • Personal history of interactions with the world/agents • The Environment • Observable by the agents • Does not directly control the agents • The Rules • Actions the agents may choose • Reactions to the environment/agents • Goal-oriented behavior • Limitations on agent behavior

  15. Why use Agents for HIV? Intuitive pairing of agents and people Simple rules can result in complex behavior Allows for observing the dynamics of individual-level decision making on the HIV epidemic Potentially useful for guiding real-world studies and interventions

  16. The Multi-Agent Simulation for HIV Transmission MASHIV

  17. MASHIV • Goal • Use JAVA to develop a multi-agent simulation of HIV for the MSM community • Determine the role of concurrency in HIV epidemics of MSM • Track and Analyze • HIV Prevalence/Incidence trends • Proportion of infections resulting from PHI • Concurrency measure of population over time

  18. MASHIV Operation • User defines parameter set • Global vs. Population parameter assignment • Population definition • Runtime • Initialization • Process User Parameters • Generate Relationship Schemas • Generate Agents • Main Loop • Update Agents • Update HIV Disease Progression • Updating Existing Relationships • Sex, HIV Transmission, Relationship Ending • Date & Add Relationships • Statistics Collection

  19. Parameters

  20. Person Agent Represents an MSM person Forms/Ends Relationships Evaluates potential partners Reacts to HIV infection

  21. Relationship Instance Agents can have different schemas and expectations for relationship.

  22. Relationship Schema Duration vs. Probabilistic Mode

  23. Relationships • Wanting to Date • Modes • Duration-based: Time since last date • Probabilistic: Probability of formation • Factors • Existing steady relationship • Number of relationships • Dating Pools • 10 random dating agents • Sexual role compatible • Both seeking same relationship type (Casual, Steady) • Steady: no repeats; Casual: repeats allowed • Dating Evaluation…

  24. Dating Evaluation

  25. The Multi-Agent Simulation for HIV Transmission MASHIV hiv model

  26. HIV Model • Initialization • Distributed to population based upon user input • HIVInstance is created • Transmission Risk • Viral load of stage determines virulence • Safe sex practice determines risk • Progression toward mortality • CD4 compartment model

  27. HIV Instance • Handles HIV progression & mortality • Logs key information • Source of Infection • Stage of infection source

  28. HIV Transmission • Condom Use • Transmission Risk • S – Stage risk multiplier • Art() - ART risk reduction

  29. HIV Transmission • Reception Risk • P() : Sexual role risk • PrEP() – PrEP risk reduction • Circ() – Circumcision risk reduction

  30. HIV Infection • Fast-moving vs. Regular Speed • Virus Stages • PHI – 90 days • Asymptomatic & AIDS • CD4 Model

  31. HIV Progression • CD4 Compartment Model • Adapted from Spectrum/EPP specification [UNAIDS] • Used to progress agents from infection to death • Compartments correlate to CD4 counts of individuals • Annual progression rates define progression between compartments and compartment mortality • Reduces progression rate to account for ART usage

  32. Lambdas

  33. Mus

  34. Alphas

  35. Transmission Probabilities Tool for viewing transmission probabilities for model

  36. A Multi-Agent Simulation of HIV MASHIV Interface

  37. Main Window & Menus

  38. Parameter Set

  39. Parameter Set

  40. Interactive Dash

  41. Interactive Dash - Running

  42. Interactive Dash

  43. Interactive Dash – Adding Set

  44. Aggregate Set Editor

  45. Aggregate Set - Running

  46. Aggregate Set - Running

  47. Progression in MASHIV Analysis tool for observing Stage & Group Progression in Model

  48. Mortality In MASHIV Tool for observing mortality without ART

  49. Mortality In MASHIV • Tool for analyzing mortality with ART • Graphs represent ART started in first CD4 group assigned • Assumes only mortality based ART failure • Lack of background mortality

  50. Questions and Answers Q&A

More Related